Abstract:A virus infection can be initiated with very few or even a single infectious virion, and as such can become extinct, i.e. stochastically fail to take hold or spread significantly. There are many ways that a fully competent infectious virion, having successfully entered a cell, can fail to cause a productive infection, i.e. one that yields infectious virus progeny. Though many discrete, stochastic mathematical models (DSMs) have been developed and used to estimate a virus infection's extinction probability, these typically neglect infection failure post viral entry. The DSM presented herein introduces parameter $\gamma\in(0,1]$ which corresponds to the probability that a virion's entry into a cell will result in a productive cell infection. We derive an expression for the likelihood of infection extinction in this new DSM, and find that prophylactic therapy with an antiviral acting to reduce $\gamma$ is best at increasing an infection's extinction probability, compared to antivirals acting on the rates of virus production or virus entry into cells. Using the DSM, we investigate the difference in the fraction of cells consumed by so-called extinct versus established virus infections, and find that this distinction becomes biologically meaningless as the probability of extinction approaches 100%. We show that infections wherein virus is release by an infected cell as a single burst, rather than at a constant rate over the cell's infectious lifespan, has the same probability of infection extinction, despite previous claims to this effect [Pearson 2011, doi:<a class="link-https link-external" data-doi="10.1371/journal.pcbi.1001058" href="https://doi.org/10.1371/journal.pcbi.1001058" rel="external noopener nofollow">https://doi.org/10.1371/journal.pcbi.1001058</a>]. Instead, extending previous work by others [Yan 2016, doi:<a class="link-https link-external" data-doi="10.1007/s00285-015-0961-5" href="https://doi.org/10.1007/s00285-015-0961-5" rel="external noopener nofollow">https://doi.org/10.1007/s00285-015-0961-5</a>], we show how the assumed distribution for the stochastic virus burst size, affects the extinction probability and associated critical antiviral efficacy.

Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population

Genetic interactions shaping evolutionary trajectories in an RNA virus population

[Variability and development of viral populations: assessment and implications]

Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies

Historical Perspective on the Discovery of the Quasispecies Concept

High-Order Epistasis and Functional Coupling of Infection Steps Drive Virus Evolution toward Independence from a Host Pathway

Rate of novel host invasion affects adaptability of evolving RNA virus lineages

Selective manipulation of the host RNA-polymerase transcription fidelity increases phenotypic mutations in an insect

Virus propagation linked to exceedingly rare gene-expression errors

Navigating a fine balance: point-mutant cheater viruses disrupt the viral replication cycle

The evolution of virulence in RNA viruses under a competition-colonization trade-off

Competition-colonization trade-off promotes coexistence of low-virulence viral strains

Viral evolution under the pressure of an adaptive immune system - optimal mutation rates for viral escape

Mutational Load Causes Stochastic Evolutionary Outcomes in Acute RNA Viral Infection

Stochastic failure of cell infection post viral entry: Implications for infection outcomes and antiviral therapy

Quasispecies in Time-Dependent Environments

"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication

Virus Replication as a Phenotypic Version of Polynucleotide Evolution

Costs and Benefits of Mutational Robustness in RNA Viruses.

Mathematical model of replication-mutation dynamics in coronaviruses

Quasineutral multistability in an epidemiological-like model for defective-helper betacoronavirus infection in cell cultures